DK1553952T3 - Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde - Google Patents

Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde

Info

Publication number: DK1553952T3
Authority: DK; Denmark
Prior art keywords: dihydroimidazolones; epilepsy; dogs; treatment
Prior art date: 2002-10-10

Application number

DK03757945T

Other languages

English (en)

Inventor

Rita Dost

Wolfgang Loescher

Andrea Tipold

Klaus Unverferth

Hans-Joachim Lankau

Chris Rundfeldt

Original Assignee

Boehringer Ingelheim Vetmed

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-10

Filing date

2003-10-09

Publication date

2009-04-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32094042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1553952(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-09 Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed

2009-04-20 Application granted granted Critical

2009-04-20 Publication of DK1553952T3 publication Critical patent/DK1553952T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK03757945T 2002-10-10 2003-10-09 Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde DK1553952T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US41759002P	2002-10-10	2002-10-10
PCT/EP2003/011212 WO2004032938A1 (en)	2002-10-10	2003-10-09	Use of dihydroimidazolones for the treatment of epilepsy in dogs

Publications (1)

Publication Number	Publication Date
DK1553952T3 true DK1553952T3 (da)	2009-04-20

Family

ID=32094042

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK14191084.4T DK2845594T3 (da)	2002-10-10	2003-10-09	Anvendelse af dihydroimidazoloner til behandlingen af hunde.
DK03757945T DK1553952T3 (da)	2002-10-10	2003-10-09	Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK14191084.4T DK2845594T3 (da)	2002-10-10	2003-10-09	Anvendelse af dihydroimidazoloner til behandlingen af hunde.

Country Status (27)

Country	Link
US (5)	US20050070537A1 (da)
EP (3)	EP2036563A1 (da)
JP (4)	JP4694202B2 (da)
KR (2)	KR101110587B1 (da)
CN (2)	CN101890019A (da)
AR (1)	AR041573A1 (da)
AT (1)	ATE418337T1 (da)
AU (2)	AU2003273978B2 (da)
BE (1)	BE2013C046I2 (da)
BR (1)	BR0315225A (da)
CA (2)	CA2501772C (da)
CY (3)	CY1109961T1 (da)
DE (1)	DE60325496D1 (da)
DK (2)	DK2845594T3 (da)
ES (2)	ES2316808T3 (da)
FR (2)	FR13C0044I2 (da)
HR (3)	HRP20200207A2 (da)
HU (2)	HUS1300035I1 (da)
LU (1)	LU92238I2 (da)
MX (1)	MXPA05003663A (da)
NZ (1)	NZ539864A (da)
PL (2)	PL238776B1 (da)
PT (2)	PT2845594T (da)
SI (2)	SI2845594T1 (da)
TW (2)	TWI324067B (da)
WO (1)	WO2004032938A1 (da)
ZA (1)	ZA200502245B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050070537A1 (en) *	2002-10-10	2005-03-31	Chris Rundfeldt	Use of dihydroimidazolones for the treatment of dogs
RU2354377C2 (ru) *	2003-07-11	2009-05-10	Берингер Ингельхайм Ветмедика Гмбх	Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
KR20140057604A (ko)	2011-08-12	2014-05-13	베링거잉겔하임베트메디카게엠베하	고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
JP6193613B2 (ja) *	2013-05-10	2017-09-06	学校法人麻布獣医学園	てんかん発作のモニタリングシステム及びモニタリング方法
US9820988B2 (en)	2014-03-24	2017-11-21	Boehringer Ingelheim Vetmedica Gmbh	Treatment of epileptic disorders in feline animals
US9856250B2 (en)	2014-05-28	2018-01-02	Toa Eiyo Ltd.	Substituted tropane derivatives
US10117891B2 (en)	2014-09-16	2018-11-06	India Globalization Capital, Inc.	Cannabinoid composition for treating pain
US10751300B2 (en)	2015-01-25	2020-08-25	India Globalization Capital, Inc.	Composition and method for treating seizure disorders
US10596159B2 (en)	2015-08-12	2020-03-24	India Globalization Capital, Inc.	Method and composition for treating cachexia and eating disorders
EP3471746A4 (en)	2016-06-15	2020-02-26	India Globalization Capital, Inc.	METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4044021A (en)	1971-10-21	1977-08-23	American Cyanamid Company	Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en)	1975-02-07	1976-01-13	Morton-Norwich Products, Inc.	1-Arylmethyl-2-imidazolidinones
US5869481A (en) *	1995-09-05	1999-02-09	Arzneitmittelwerk Dresden G.M.B.H.	Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
DE19532668A1 (de)	1995-09-05	1997-03-06	Dresden Arzneimittel	Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
DE19721580A1 (de) *	1997-05-23	1998-11-26	Dresden Arzneimittel	Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
CA2297723A1 (en) *	1997-06-26	1999-01-07	The Board Of Regents Of The University Of Texas	Synthesis of dihydrohonokiol compositions
JP4669095B2 (ja)	1999-07-19	2011-04-13	太陽化学株式会社	ペットの問題行動抑制組成物
EP1485094B2 (de)	2002-03-07	2020-03-25	Boehringer Ingelheim International GmbH	Oral zu applizierende darreichungsform für 3- [(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester oder dessen salze
US20050070537A1 (en) *	2002-10-10	2005-03-31	Chris Rundfeldt	Use of dihydroimidazolones for the treatment of dogs
DE10339862A1 (de) *	2003-08-29	2005-03-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
KR20140057604A (ko)	2011-08-12	2014-05-13	베링거잉겔하임베트메디카게엠베하	고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
US9820988B2 (en)	2014-03-24	2017-11-21	Boehringer Ingelheim Vetmedica Gmbh	Treatment of epileptic disorders in feline animals

2003
- 2003-10-06 US US10/680,459 patent/US20050070537A1/en not_active Abandoned
- 2003-10-08 TW TW092127976A patent/TWI324067B/zh not_active IP Right Cessation
- 2003-10-08 TW TW098142077A patent/TWI424849B/zh not_active IP Right Cessation
- 2003-10-09 EP EP08167818A patent/EP2036563A1/en not_active Ceased
- 2003-10-09 CA CA2501772A patent/CA2501772C/en not_active Expired - Lifetime
- 2003-10-09 NZ NZ539864A patent/NZ539864A/en not_active IP Right Cessation
- 2003-10-09 DK DK14191084.4T patent/DK2845594T3/da active
- 2003-10-09 PT PT141910844T patent/PT2845594T/pt unknown
- 2003-10-09 MX MXPA05003663A patent/MXPA05003663A/es active IP Right Grant
- 2003-10-09 ES ES03757945T patent/ES2316808T3/es not_active Expired - Lifetime
- 2003-10-09 EP EP14191084.4A patent/EP2845594B1/en not_active Expired - Lifetime
- 2003-10-09 HR HRP20200207AA patent/HRP20200207A2/hr not_active Application Discontinuation
- 2003-10-09 KR KR1020057006150A patent/KR101110587B1/ko not_active Expired - Lifetime
- 2003-10-09 PL PL397320A patent/PL238776B1/pl unknown
- 2003-10-09 AR ARP030103685A patent/AR041573A1/es unknown
- 2003-10-09 DE DE60325496T patent/DE60325496D1/de not_active Expired - Lifetime
- 2003-10-09 ES ES14191084T patent/ES2908453T3/es not_active Expired - Lifetime
- 2003-10-09 SI SI200332622T patent/SI2845594T1/sl unknown
- 2003-10-09 WO PCT/EP2003/011212 patent/WO2004032938A1/en not_active Ceased
- 2003-10-09 DK DK03757945T patent/DK1553952T3/da active
- 2003-10-09 AU AU2003273978A patent/AU2003273978B2/en not_active Expired
- 2003-10-09 CA CA2727722A patent/CA2727722C/en not_active Expired - Lifetime
- 2003-10-09 PL PL374603A patent/PL214702B1/pl unknown
- 2003-10-09 CN CN2010101440231A patent/CN101890019A/zh active Pending
- 2003-10-09 EP EP03757945A patent/EP1553952B1/en not_active Expired - Lifetime
- 2003-10-09 SI SI200331504T patent/SI1553952T1/sl unknown
- 2003-10-09 CN CN2003801057558A patent/CN1726040B/zh not_active Expired - Lifetime
- 2003-10-09 PT PT03757945T patent/PT1553952E/pt unknown
- 2003-10-09 KR KR1020117009632A patent/KR20110063843A/ko not_active Ceased
- 2003-10-09 JP JP2004542480A patent/JP4694202B2/ja not_active Expired - Lifetime
- 2003-10-09 HR HRP20090667AA patent/HRP20090667B1/hr not_active IP Right Cessation
- 2003-10-09 AT AT03757945T patent/ATE418337T1/de active
- 2003-10-09 HR HRP20050322AA patent/HRP20050322B1/hr not_active IP Right Cessation
- 2003-10-09 BR BR0315225-1A patent/BR0315225A/pt not_active Application Discontinuation
2005
- 2005-03-17 ZA ZA2005/02245A patent/ZA200502245B/en unknown
2007
- 2007-07-18 US US11/879,708 patent/US8859540B2/en not_active Expired - Lifetime
2009
- 2009-03-20 CY CY20091100314T patent/CY1109961T1/el unknown
- 2009-10-12 AU AU2009225322A patent/AU2009225322A1/en not_active Abandoned
2010
- 2010-12-28 JP JP2010293113A patent/JP2011068685A/ja not_active Withdrawn
2012
- 2012-09-14 US US13/616,440 patent/US8962617B2/en not_active Expired - Lifetime
2013
- 2013-07-03 LU LU92238C patent/LU92238I2/fr unknown
- 2013-07-03 BE BE2013C046C patent/BE2013C046I2/fr unknown
- 2013-07-11 CY CY2013031C patent/CY2013031I1/el unknown
- 2013-07-24 HU HUS1300035C patent/HUS1300035I1/hu unknown
- 2013-07-24 FR FR13C0044C patent/FR13C0044I2/fr active Active
2014
- 2014-02-14 JP JP2014026704A patent/JP6249812B2/ja not_active Expired - Lifetime
- 2014-11-17 US US14/542,888 patent/US9469611B2/en not_active Expired - Fee Related
2016
- 2016-02-29 JP JP2016038151A patent/JP2016104817A/ja not_active Withdrawn
- 2016-08-30 US US15/251,022 patent/US20160367562A1/en not_active Abandoned
2022
- 2022-03-31 CY CY20221100250T patent/CY1125103T1/el unknown
- 2022-06-30 FR FR22C1033C patent/FR22C1033I1/fr active Active
- 2022-07-28 HU HUS2200036C patent/HUS2200036I1/hu unknown

Also Published As

Publication number	Publication date
JP4694202B2 (ja)	2011-06-08
FR13C0044I1 (da)	2013-08-30
CY1125103T1 (el)	2023-01-05
US8962617B2 (en)	2015-02-24
US20160367562A1 (en)	2016-12-22
US9469611B2 (en)	2016-10-18
SI1553952T1 (sl)	2009-04-30
FR22C1033I1 (fr)	2022-09-09
AR041573A1 (es)	2005-05-18
FR13C0044I2 (fr)	2014-03-07
DE60325496D1 (de)	2009-02-05
CN101890019A (zh)	2010-11-24
CA2501772A1 (en)	2004-04-22
EP2036563A1 (en)	2009-03-18
HK1085920A1 (zh)	2006-09-08
PL214702B1 (pl)	2013-09-30
NZ539864A (en)	2007-11-30
PL238776B1 (pl)	2021-10-04
EP1553952A1 (en)	2005-07-20
WO2004032938A1 (en)	2004-04-22
US20080027057A1 (en)	2008-01-31
AU2003273978A1 (en)	2004-05-04
MXPA05003663A (es)	2005-06-08
PL397320A1 (pl)	2012-02-13
HUS1300035I1 (hu)	2017-10-30
CY1109961T1 (el)	2014-09-10
ES2316808T3 (es)	2009-04-16
JP2014080449A (ja)	2014-05-08
KR20050056237A (ko)	2005-06-14
US20050070537A1 (en)	2005-03-31
HRP20090667A2 (hr)	2010-07-31
JP6249812B2 (ja)	2017-12-20
CN1726040B (zh)	2010-05-12
JP2006503873A (ja)	2006-02-02
US8859540B2 (en)	2014-10-14
BE2013C046I2 (da)	2022-08-09
US20150072983A1 (en)	2015-03-12
HRP20050322B1 (hr)	2013-12-06
CN1726040A (zh)	2006-01-25
LU92238I2 (fr)	2013-09-03
ES2908453T3 (es)	2022-04-29
HRP20090667B1 (hr)	2021-06-11
KR20110063843A (ko)	2011-06-14
US20130065898A1 (en)	2013-03-14
PT2845594T (pt)	2022-03-09
TWI424849B (zh)	2014-02-01
AU2003273978B2 (en)	2009-07-23
CY2013031I2 (el)	2015-11-04
HRP20050322A2 (en)	2006-05-31
CY2013031I1 (el)	2015-11-04
KR101110587B1 (ko)	2012-02-15
TW200503726A (en)	2005-02-01
CA2727722A1 (en)	2004-04-22
ZA200502245B (en)	2005-11-30
TW201010706A (en)	2010-03-16
EP1553952B1 (en)	2008-12-24
HUS2200036I1 (hu)	2022-08-28
SI2845594T1 (sl)	2022-04-29
BR0315225A (pt)	2005-08-23
AU2009225322A1 (en)	2009-11-05
TWI324067B (en)	2010-05-01
CA2501772C (en)	2011-08-23
JP2016104817A (ja)	2016-06-09
JP2011068685A (ja)	2011-04-07
DK2845594T3 (da)	2022-03-07
CA2727722C (en)	2013-05-28
HRP20200207A2 (hr)	2020-07-24
EP2845594A1 (en)	2015-03-11
ATE418337T1 (de)	2009-01-15
PL374603A1 (en)	2005-10-31
LU92238I9 (da)	2019-01-09
PT1553952E (pt)	2009-02-10
EP2845594B1 (en)	2022-02-23

Publication	Publication Date	Title
DE60319273D1 (de)	2008-04-03	Entzunderungsdüse
DK1474420T3 (da)	2012-05-21	Quinazolinforbindelser
NL1025404A1 (nl)	2004-08-09	Pyrazolo-triazine verbindingen en gebruik daarvan.
DK1667992T3 (da)	2007-04-30	Quinazolinderivater
DE602004002966D1 (de)	2006-12-07	Spritzdüse
DK1575597T3 (da)	2009-03-16	Anvendelse af rimexolon til behandling af öjentörhed
DE602004027504D1 (de)	2010-07-15	Aminobenzophenonverbindungen
CY2013031I2 (el)	2015-11-04	Χρηση διϋδροϊμιδαζολονων για την αγωγη της επιληψιας στους σκυλους
ATE379983T1 (de)	2007-12-15	Klettverschluss
DE602004016590D1 (de)	2008-10-30	Einspritzventil
DE60315063D1 (de)	2007-08-30	Elektrokontaktelement
DK1678085T3 (da)	2010-08-23	Fluidbehandlingsindretning
NO20050689L (no)	2005-03-21	Terapeutisk anvendelse
DE60329308D1 (de)	2009-10-29	Oberflächenbehandlung
DE602004009212D1 (de)	2007-11-08	Fluidstrahlbohrwerkzeug
DE502004005095D1 (de)	2007-11-08	Einspritzdüse
DE502004009781D1 (de)	2009-09-03	Einspritzventil
DE502004005873D1 (de)	2008-02-14	Einspritzdüse
FI20021374A7 (fi)	2004-01-13	Jätevedenkäsittely-yksikkö
DK1636140T3 (da)	2012-07-09	Mindre enhed til behandling af spildevand
NO20053898D0 (no)	2005-08-19	Use and proceeding at footballshoes
FI116938B (fi)	2006-04-13	Jäteveden puhdistamo
NO20034256D0 (no)	2003-09-24	Behandlingsmetode
NO20031166D0 (no)	2003-03-13	Behandlingsmetode
NO20024831D0 (no)	2002-10-07	Behandlingsmetode